McDowell Caryn Gordon

Number of records: 27
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
08-Jun-22 4:09 PM
View: 
Quince Therapeutics, Inc. (QNCX) 06-Jun-22Payment of Exercise 6,700$2.86$19,183.40(5%)
140.0K to 133.3K
08-Jun-22 4:09 PM
View: 
Quince Therapeutics, Inc. (QNCX) 06-Jun-22Sale 10,800$2.86$30,922.60(8%)
133.3K to 122.5K
04-Mar-22 5:57 PM
View: 
Quince Therapeutics, Inc. (QNCX) 03-Mar-22Grant 140,000----100%
0 to 140.0K
19-Feb-20 8:23 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Feb-20Payment of Exercise 864$25.33$21,885.10(4%)
24.32K to 23.45K
(9%)
03-Jan-20 6:46 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-19Acquisition (other) 382$10.82$4,133.242%
23.93K to 24.32K
1%
02-Jul-19 9:14 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Jun-19Acquisition (other) 1,000$11.02$11,024.504%
22.93K to 23.93K
(< 1%)
17-Jun-19 8:30 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Jun-19Payment of Exercise 1,383$10.86$15,019.40(6%)
24.32K to 22.93K
(154%)
25-Jan-19 8:54 PM
View: 
Revance Therapeutics, Inc. (RVNC) 24-Jan-19Grant 7,500----45%
16.82K to 24.32K
02-Jan-19 8:05 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-18Acquisition (other) 818$17.11$13,996.405%
16.0K to 16.82K
03-May-18 8:23 PM
View: 
Revance Therapeutics, Inc. (RVNC) 01-May-18Grant 16,000----100%
0 to 16.0K
01-Mar-18 7:12 PM
View: 
Cytokinetics Inc. (CYTK) 28-Feb-18Payment of Exercise 2,452$7.75$19,003.00(7%)
35.0K to 32.55K
(171%)
01-Mar-18 7:12 PM
View: 
Cytokinetics Inc. (CYTK) 27-Feb-18Grant 20,000$0.00$20.00133%
15.0K to 35.0K
18-Jan-18 8:10 PM
View: 
Cytokinetics Inc. (CYTK) 16-Jan-18Option Exercise 2,709$6.53$17,694.0018%
15.0K to 17.71K
18-Jan-18 8:10 PM
View: 
Cytokinetics Inc. (CYTK) 16-Jan-18Market Option Sale (Planned) 2,709$9.00$24,381.00(15%)
17.71K to 15.0K
(134%)
06-Nov-17 8:19 PM
View: 
Cytokinetics Inc. (CYTK) 02-Nov-17Option Exercise 1,355$6.53$8,850.358%
17.91K to 19.26K
06-Nov-17 8:19 PM
View: 
Cytokinetics Inc. (CYTK) 02-Nov-17Market Option Sale (Planned) 1,355$12.94$17,536.80(7%)
19.26K to 17.91K
(62%)
06-Nov-17 8:19 PM
View: 
Cytokinetics Inc. (CYTK) 02-Nov-17Market Sale (Planned) 2,905$12.94$37,597.20(16%)
17.91K to 15.0K
(62%)
10-Oct-17 7:20 PM
View: 
Cytokinetics Inc. (CYTK) 06-Oct-17Option Exercise 11,583$6.51$75,351.5063%
18.37K to 29.95K
10-Oct-17 7:20 PM
View: 
Cytokinetics Inc. (CYTK) 06-Oct-17Market Option Sale (Planned) 11,583$15.49$179,410.00(39%)
29.95K to 18.37K
(36%)
10-Oct-17 7:20 PM
View: 
Cytokinetics Inc. (CYTK) 06-Oct-17Market Sale (Planned) 1,598$15.49$24,751.60(9%)
18.37K to 16.77K
(36%)
08-Sep-17 4:48 PM
View: 
Cytokinetics Inc. (CYTK) 06-Sep-17Option Exercise 10,231$6.50$66,521.2056%
18.37K to 28.6K
08-Sep-17 4:48 PM
View: 
Cytokinetics Inc. (CYTK) 06-Sep-17Market Option Sale (Planned) 10,131$14.60$147,864.00(35%)
28.6K to 18.47K
(44%)
08-Sep-17 4:48 PM
View: 
Cytokinetics Inc. (CYTK) 06-Sep-17Market Sale (Planned) 100$15.00$1,500.00(< 1%)
18.47K to 18.37K
(40%)
10-Aug-17 7:56 PM
View: 
Cytokinetics Inc. (CYTK) 08-Aug-17Option Exercise 9,538$6.50$61,995.2047%
20.18K to 29.72K
10-Aug-17 7:56 PM
View: 
Cytokinetics Inc. (CYTK) 08-Aug-17Market Option Sale (Planned) 9,538$12.47$118,903.00(32%)
29.72K to 20.18K
(69%)
10-Aug-17 7:56 PM
View: 
Cytokinetics Inc. (CYTK) 08-Aug-17Market Sale (Planned) 1,810$12.47$22,563.90(9%)
20.18K to 18.37K
(69%)
02-Mar-17 7:06 PM
View: 
Cytokinetics Inc. (CYTK) 28-Feb-17Grant 15,000$0.00$15.00419%
3.58K to 18.58K